Essential medicines for breast cancer in low and middle income countries

Docetaxel for the adjuvant treatment of early node-positive breast cancer: a single technology appraisal

(2014) J Chilcott et al.   HEALTH TECHNOLOGY ASSESSMENT

Essential Medicines Are More Available than Other Medicines around the Globe

(2014) Yaser T. Bazargani et al.   PLoS One

Receptor-Defined Subtypes of Breast Cancer in Indigenous Populations in Africa: A Systematic Review and Meta-Analysis

(2014) Amanda Eng et al.   PLOS MEDICINE

Cost comparison and economic implications of commonly used originator and generic chemotherapy drugs in India

(2013) G. d. L. Lopes   ANNALS OF ONCOLOGY

Selection of oncology medicines in low- and middle-income countries

(2013) Y. T. Bazargani et al.   ANNALS OF ONCOLOGY

Cancer Surgery in Low-Income Countries

(2013) David E. Gyorki et al.   ARCHIVES OF SURGERY

Planning cancer control in Latin America and the Caribbean

(2013) Paul E Goss et al.   LANCET ONCOLOGY

1st International consensus guidelines for advanced breast cancer (ABC 1)

(2012) F. Cardoso et al.   BREAST

New Developments and Future Directions in Systemic Therapy

(2012) A. Sheri et al.   CLINICAL ONCOLOGY

Therapeutic Antibodies Against Cancer

(2012) Mark J. Adler et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Christopher J L Murray et al.   LANCET

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Breast cancer in Brazil: present status and future goals

(2012) Brittany L Lee et al.   LANCET ONCOLOGY

Breast cancer in Mexico: a growing challenge to health and the health system

(2012) Yanin Chávarri-Guerra et al.   LANCET ONCOLOGY

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Breast cancer management in low resource countries (LRCs): Consensus statement from the Breast Health Global Initiative

(2011) Nagi S. El Saghir et al.   BREAST

Breast cancer management in middle-resource countries (MRCs): Consensus statement from the Breast Health Global Initiative

(2011) Cheng-Har Yip et al.   BREAST

Developing Nations Face Challenges as Breast Cancer Rises

(2011) V. Brower   JNCI-Journal of the National Cancer Institute

Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010

(2011) Benjamin O Anderson et al.   LANCET ONCOLOGY

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

(2011) Dennis Slamon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Locally advanced breast cancer

(2009) Nagi S. El Saghir et al.   CANCER

Guideline implementation for breast healthcare in low- and middle-Income countries: Treatment resource allocation

(2009) Alexandru Eniu et al.   CANCER

Breast cancer as a global health concern

(2009) Steven S. Coughlin et al.   Cancer Epidemiology

Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009

(2009) Nan Soon Wong et al.   LANCET ONCOLOGY

Adjuvant Trastuzumab Therapy for HER2-Positive Breast Cancer

(2008) Mohammad Jahanzeb   Clinical Breast Cancer